2006

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer (October 26, 2006) READ MORE >>

Koronis Presents Invited Talk on KP-1461 at the 2006 International Meeting of the Institute of Human Virology (November 17, 2006)

Koronis Presents at the Rodman & Renshaw Healthcare Conference 2006 at the Palace Hotel, New York, NY. Board Chairman and Interim CEO Donald Elmer Provides a Corporate Update (November 6, 2006)

Koronis Presents at the BIO Investorforum 2006 at the Palace Hotel, San Franciso, CA. Board Chairman and Interim CEO Donald Elmer Provides a Corporate Update (October 18, 2006)

Koronis Presents at the Pacific Growth Equities 2006 Life Sciences Growth Conference at the Intercontinental Mark Hopkins Hotel, San Francisco (June 12, 2006)

Koronis Pharmaceuticals Presents at the Annual Invest Northwest Investor-CEO Forum at the Bell Harbor International Conference Center, Seattle (March 22, 2006)

Koronis Pharmaceuticals Participates in Panel "Infectious Disease: Next Wave of HIV Drugs" at BIO CEO & Investor Conference (February 9, 2006) READ MORE >>

2005

Koronis Pharmaceuticals Begins Phase 1b Clinical Trial of Novel Anti-Viral HIV/AIDS therapeutic in HIV-Positive Patients. (October 12, 2005)   READ MORE >>

Koronis Files an Amendment to its IND to Begin Phase 1b Clinical Trials of its Anti-Viral Drug KP-1461 (May 27, 2005)

Koronis Announces Completion of Enrollment in Phase 1a Trial of KP-1461 (March 18, 2005)

2004

Koronis Initiates Phase 1a Clinical Trials with its Anti-HIV Drug, KP-1461 (November 30, 2004)

Koronis Receives FDA Approval to Begin Human Clinical Trials with its Anti-HIV Drug, KP-1461 (November 17, 2004)

Koronis Files an IND with FDA to Begin Human Clinical Trials with its Anti-HIV Drug, KP-1461 (August 4, 2004)

Stay Informed

To keep updated on Koronis' latest events and news releases, please send an email to Julie@rathbuncomm.com to be added to our email news distribution list.